213 related articles for article (PubMed ID: 14607673)
1. Administration of tacrolimus in 50 liver transplantation patients.
Ye QF; Ruzig MA; Gong NQ
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):492-4. PubMed ID: 14607673
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
Yu LX; Shan HT; Fu SJ; Du CF; Ma JJ; Xu J; Deng WF; Wang YB
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.
Platz KP; Mueller AR; Blumhardt G; Bachmann S; Bechstein WO; Kahl A; Neuhaus P
Transplantation; 1994 Jul; 58(2):170-8. PubMed ID: 7518975
[TBL] [Abstract][Full Text] [Related]
4. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.
Lee JT; Whitson BA; Kelly RF; D'Cunha J; Dunitz JM; Hertz MI; Shumway SJ
J Surg Res; 2013 Sep; 184(1):599-604. PubMed ID: 23566442
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
[TBL] [Abstract][Full Text] [Related]
7. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
8. Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy.
Ji SM; Li LS; Sha GZ; Chen JS; Liu ZH
Transplant Proc; 2007 Jun; 39(5):1402-5. PubMed ID: 17580148
[TBL] [Abstract][Full Text] [Related]
9. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation.
Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Kido K; Taki J; Aomatsu Y; Kin T; Yagura K; Ohyama T; Ohashi K; Yamada T; Nakano H
Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229
[TBL] [Abstract][Full Text] [Related]
10. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
[TBL] [Abstract][Full Text] [Related]
11. Comparison between effects of cyclosporine and tacrolimus on glomerular filtration rate in pediatric post-orthotopic liver transplant patients.
Loo RM; Ariyarajah V; Oh C; Shen L; Aw MM; Prabhakaran K
Pediatr Transplant; 2006 Feb; 10(1):55-9. PubMed ID: 16499588
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506).
Small SL; Fukui MB; Bramblett GT; Eidelman BH
Ann Neurol; 1996 Oct; 40(4):575-80. PubMed ID: 8871576
[TBL] [Abstract][Full Text] [Related]
13. [A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions].
Sakane T; Mochizuki M; Inaba G; Masuda K
Ryumachi; 1995 Oct; 35(5):802-13. PubMed ID: 8594659
[TBL] [Abstract][Full Text] [Related]
14. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of efficacy and safety on steroid withdraw at the seventh day after liver transplantation].
Hu AB; He XS; Wu ZP; Zhu XF; Ma Y; Wang DP; Wang GD; Tai Q; Ju WQ; Wu LW; Huang JF
Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1126-8. PubMed ID: 19094670
[TBL] [Abstract][Full Text] [Related]
16. Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants.
Hedayat S; Kershner RP; Su G
J Biopharm Stat; 1996 Nov; 6(4):411-24. PubMed ID: 8969977
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic administration of tacrolimus and cyclosporine on human gastrointestinal permeability.
Parrilli G; Abazia C; Sarnelli G; Corsaro MM; Coccoli P; Viglione L; Cuomo R; Budillon G
Liver Transpl; 2003 May; 9(5):484-8. PubMed ID: 12740791
[TBL] [Abstract][Full Text] [Related]
19. [Effects of tacrolimus vs cyclosporin-A on bone metabolism after kidney transplantation: a cross-sectional study in 28 patients].
Albano L; Casez JP; Bekri S; Gigante M; Champenois I; Cassuto-Viguier E; Jaeger P
Nephrol Ther; 2005 May; 1(2):115-20. PubMed ID: 16895674
[TBL] [Abstract][Full Text] [Related]
20. Long-term therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis.
Tada M; Shimohata T; Tada M; Oyake M; Igarashi S; Onodera O; Naruse S; Tanaka K; Tsuji S; Nishizawa M
J Neurol Sci; 2006 Aug; 247(1):17-20. PubMed ID: 16631797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
